These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 34624486)
1. Identification of immune infiltration-related LncRNA FAM83C-AS1 for predicting prognosis and immunotherapy response in colon cancer. Li G; Feng H; Chen Q; Xue C; Li M; Liu X; Ma S Transpl Immunol; 2021 Dec; 69():101481. PubMed ID: 34624486 [TBL] [Abstract][Full Text] [Related]
2. LncRNA ST7-AS1 is a Potential Novel Biomarker and Correlated With Immune Infiltrates for Breast Cancer. Zhang Z; Zhang H; Li D; Zhou X; Wang J; Zhang Q Front Mol Biosci; 2021; 8():604261. PubMed ID: 33912584 [No Abstract] [Full Text] [Related]
3. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer. Chen B; Lu X; Zhou Q; Chen Q; Zhu S; Li G; Liu H PLoS One; 2023; 18(8):e0290031. PubMed ID: 37582104 [TBL] [Abstract][Full Text] [Related]
4. LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis. Yang W; Ge F; Lu S; Shan Z; Peng L; Chai J; Liu H; Li B; Zhang Z; Huang J; Hua Y; Zhang Y Front Med (Lausanne); 2021; 8():795427. PubMed ID: 34926534 [TBL] [Abstract][Full Text] [Related]
5. Upregulation of OTX2-AS1 is Associated With Immune Infiltration and Predicts Prognosis of Gastric Cancer. Han QL; Cui Z; Wang Q; Pang F; Li D; Wang D Technol Cancer Res Treat; 2023; 22():15330338231154091. PubMed ID: 36740995 [TBL] [Abstract][Full Text] [Related]
6. The oncogenic role of LncRNA FAM83C-AS1 in colorectal cancer development by epigenetically inhibits SEMA3F via stabilizing EZH2. Xue W; Wang F; Han P; Liu Y; Zhang B; Gu X; Wang Y; Li M; Zhao Y; Cui B Aging (Albany NY); 2020 Oct; 12(20):20396-20412. PubMed ID: 33109776 [TBL] [Abstract][Full Text] [Related]
7. LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma. Lin Y; Li Y; Chen Y; Zhang Z Medicine (Baltimore); 2022 Oct; 101(42):e31314. PubMed ID: 36281164 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway. Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic significance of long noncoding RNA SSTR5-AS1 in patients with gastric cancer. Cheng Y; Di J; Wu J; Shi HT; Zou BC; Zhang Y; Xie DH Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5385-5390. PubMed ID: 32495873 [TBL] [Abstract][Full Text] [Related]
10. Low Expression of Long Noncoding RNA SLC26A4 Antisense RNA 1 Is an Independent Prognostic Biomarker and Correlate of Immune Infiltrates in Breast Cancer. Yi W; Shen H; Sun D; Xu Y; Feng Y; Li D; Wang C Med Sci Monit; 2021 Dec; 27():e934522. PubMed ID: 34880202 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
12. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer. Xiao R; Yang M; Tan Y; Ding R; Li D Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952 [TBL] [Abstract][Full Text] [Related]
13. High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration. Wang HY; Xie Y; Du H; Luo B; Li Z PeerJ; 2023; 11():e16104. PubMed ID: 37810780 [TBL] [Abstract][Full Text] [Related]
14. Value of long non-coding RNA HAS2-AS1 as a diagnostic and prognostic marker of glioma. You A; Gu J; Wang J; Li J; Zhang Y; Rao G; Ge X; Zhang K; Gao X; Wang D Neurologia (Engl Ed); 2024 May; 39(4):353-360. PubMed ID: 38616063 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma. Liao C; Wang A; Ma Y; Liu H Medicine (Baltimore); 2021 Oct; 100(40):e27473. PubMed ID: 34622876 [TBL] [Abstract][Full Text] [Related]
16. Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer. Lin Y; Xiao Y; Liu S; Hong L; Shao L; Wu J BMC Med Genomics; 2022 Oct; 15(1):221. PubMed ID: 36280825 [TBL] [Abstract][Full Text] [Related]
17. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma. Xu Q; Wang Y; Huang W Int Immunopharmacol; 2021 Mar; 92():107333. PubMed ID: 33486322 [TBL] [Abstract][Full Text] [Related]
18. LncRNA ELF3-AS1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma. Chen T; Zhu C; Wang X; Pan Y Can J Gastroenterol Hepatol; 2021; 2021():8323487. PubMed ID: 34336727 [TBL] [Abstract][Full Text] [Related]
19. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma. Huang W; Liu Z; Li Y; Liu L; Mai G J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368 [TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]